Numerous studies have shown that TTK expression is abnormally increased in various types of human malignancies, such as triple-negative breast cancer, pancreatic cancer, and hepatocellular carcinoma, and contributes to cancer promotion and, in some cases, poor prognosis [38,39,40,41]. Here, TTK is linked to triple-negative breast carcinoma.